Dr. Robert Michael Fairchild, MD, PhD

Dr. Fairchild practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Fairchild's NPI, 1255607214, was assigned on March 23, 2012. Dr. Fairchild graduated from Vagelos College of Physicians and Surgeons in 2012. Dr. Fairchild holds California license A126504.

Dr. Fairchild's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Fairchild's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Fairchild is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Fairchild to 1 more hospital and 1 group practice or clinic, each named with a free account. Dr. Fairchild's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fairchild practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Fairchild's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Fairchild is board certified in internal medicine by the American Board of Internal Medicine. Dr. Fairchild is licensed in California.

Dmand AI lists arteritis, gout, joint pain, muscle pain, fibromyalgia, and limb pain and rheumatoid arthritis among the conditions Dr. Fairchild treats.

CMS data shows 446 Medicare services from Dr. Fairchild across 9 procedure codes in 2024, for 216 Medicare patients. Medicare paid $28,567 for them.

CMS counts 216 Medicare patients who saw Dr. Fairchild in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have arthritis, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fairchild's median patient age at 55, with 72% women.

In 2024, Dr. Fairchild wrote 462 Medicare Part D claims for 69 patients. 66% of them were for generic drugs. CMS names the drug for 380 of them, across 12 drugs with 11 or more claims each, at $653,142 in total drug cost. In 2023, CMS named 327 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Fairchild for performance year 2024, reported as part of a group. Dr. Fairchild accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fairchild as offering telehealth.

Dmand AI links 20 papers to Dr. Fairchild, published from 2016 to 2025. 2021 was the busiest year, with 5. The most frequent topics are Ultrasonography, Tomography, X-Ray Computed and Lung. Dr. Fairchild has published most often in Arthritis Care Res (Hoboken). Dr. Fairchild's most frequent co-authors are Lorinda Susan Chung, MD, Matthew Charles Baker, MD and Audra Horomanski, MD.

CMS Open Payments shows 9 general payments to Dr. Fairchild from 8 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $131.

Dr. Fairchild graduated from Vagelos College of Physicians and Surgeons in 2012.

Dr. Fairchild is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and Elevance. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.